Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Favorable radiation field decrease in gastric marginal zone lymphoma : Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL).

Reinartz G, Pyra RP, Lenz G, Liersch R, Stüben G, Micke O, Willborn K, Hess CF, Probst A, Fietkau R, Jany R, Schultze J, Rübe C, Hirt C, Fischbach W, Bentz M, Daum S, Pott C, Tiemann M, Möller P, Neubauer A, Wilhelm M, Willich N, Berdel WE, Eich HT.

Strahlenther Onkol. 2019 Jun;195(6):544-557. doi: 10.1007/s00066-019-01446-5. Epub 2019 Mar 11.

PMID:
30859254
2.

Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases.

Schliemann C, Kerkhoff A, Hesse P, Bröckling S, Hardes J, Streitbürger A, Andreou D, Gosheger G, Elges S, Wardelmann E, Hartmann W, Mesters R, Lenz G, Willich N, Kriz J, Eich H, Berdel WE, Kessler T.

PLoS One. 2018 May 22;13(5):e0197315. doi: 10.1371/journal.pone.0197315. eCollection 2018.

3.

Lung toxicity after radiation in childhood: Results of the International Project on Prospective Analysis of Radiotoxicity in Childhood and Adolescence.

Stoppel G, Eich HT, Matuschek C, Kortmann RD, Meyer F, Martinsson U, Nilsson K, Kristensen I, Vordermark D, Willich N, Christiansen H, Koch R, Steinmann D.

Radiother Oncol. 2017 Nov;125(2):286-292. doi: 10.1016/j.radonc.2017.09.026. Epub 2017 Oct 16.

PMID:
29050956
4.

Acute Toxicity Grade 3 and 4 After Irradiation in Children and Adolescents: Results From the IPPARCA Collaboration.

Pixberg C, Koch R, Eich HT, Martinsson U, Kristensen I, Matuschek C, Kortmann RD, Pohl F, Elsayad K, Christiansen H, Willich N, Lindh J, Steinmann D.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):792-9. doi: 10.1016/j.ijrobp.2015.12.353. Epub 2015 Dec 19.

PMID:
26972652
5.

Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma.

Elsayad K, Kriz J, Moustakis C, Scobioala S, Reinartz G, Haverkamp U, Willich N, Weishaupt C, Stadler R, Sunderkötter C, Eich HT.

Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):1077-86. doi: 10.1016/j.ijrobp.2015.08.041. Epub 2015 Sep 5.

PMID:
26581145
6.

[Approval procedures for clinical trials in the field of radiation oncology].

Simon M, Habeck M, Büttner D, Habeck U, Nölling T, Krause M, Brix G, Willich N, Wenz F, Schmidberger H, Debus J, Baumann M.

Strahlenther Onkol. 2015 Dec;191(12):909-20. doi: 10.1007/s00066-015-0914-3. German.

PMID:
26501140
7.

Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe.

Bölling T, Braun-Munzinger G, Burdach S, Calaminus G, Craft A, Delattre O, Deley MC, Dirksen U, Dockhorn-Dworniczak B, Dunst J, Engel S, Faldum A, Fröhlich B, Gadner H, Göbel U, Gosheger G, Hardes J, Hawkins DS, Hjorth L, Hoffmann C, Kovar H, Kruseova J, Ladenstein R, Leuschner I, Lewis IJ, Oberlin O, Paulussen M, Potratz J, Ranft A, Rössig C, Rübe C, Sauer R, Schober O, Schuck A, Timmermann B, Tirode F, van den Berg H, van Valen F, Vieth V, Willich N, Winkelmann W, Whelan J, Womer RB.

Klin Padiatr. 2015 May;227(3):108-15. doi: 10.1055/s-0035-1545263. Epub 2015 May 18.

PMID:
25985445
8.

Hepatotoxicity after liver irradiation in children and adolescents : results from the RiSK.

Rösler P, Christiansen H, Kortmann RD, Martini C, Matuschek C, Meyer F, Rübe C, Langer T, Koch R, Eich HT, Willich N, Steinmann D.

Strahlenther Onkol. 2015 May;191(5):413-20. doi: 10.1007/s00066-014-0796-9. Epub 2014 Dec 9.

PMID:
25487695
9.

Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey.

Grau C, Defourny N, Malicki J, Dunscombe P, Borras JM, Coffey M, Slotman B, Bogusz M, Gasparotto C, Lievens Y; HERO consortium, Kokobobo A, Sedlmayer F, Slobina E, Feyen K, Hadjieva T, Odrazka K, Grau Eriksen J, Jaal J, Bly R, Chauvet B, Willich N, Polgar C, Johannsson J, Cunningham M, Magrini S, Atkocius V, Untereiner M, Pirotta M, Karadjinovic V, Levernes S, Sladowski K, Lurdes Trigo M, Šegedin B, Rodriguez A, Lagerlund M, Pastoors B, Hoskin P, Vaarkamp J, Cleries Soler R.

Radiother Oncol. 2014 Aug;112(2):155-64. doi: 10.1016/j.radonc.2014.08.029. Epub 2014 Oct 31.

10.

Evaluation of the time required for overhead tasks performed by physicians, medical physicists, and technicians in radiation oncology institutions: the DEGRO-QUIRO study.

Sack C, Sack H, Willich N, Popp W.

Strahlenther Onkol. 2015 Feb;191(2):113-24. doi: 10.1007/s00066-014-0758-2. Epub 2014 Sep 23.

PMID:
25245470
11.

Acute and late side effects to salivary glands and oral mucosa after head and neck radiotherapy in children and adolescents. Results of the "Registry for the evaluation of side effects after radiotherapy in childhood and adolescence".

Bölling T, Weege J, Eich HT, Timmermann B, Meyer FM, Rübe C, Kortmann RD, Fischedick K, Rödel C, Koch R, Willich N.

Head Neck. 2015 Aug;37(8):1137-41. doi: 10.1002/hed.23715. Epub 2014 Jul 11.

PMID:
24764129
12.

Evaluation of time, attendance of medical staff and resources for radiotherapy in pediatric and adolescent patients. The DEGRO-QUIRO trial.

Zabel-du Bois A, Milker-Zabel S, Bruns F, Christiansen H, Ernst I, Willich N, Popp W, Debus J, Sack H.

Strahlenther Onkol. 2014 Jun;190(6):582-90. doi: 10.1007/s00066-014-0619-z. Epub 2014 Apr 1.

PMID:
24687562
13.

Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.

Wiegel T, Bartkowiak D, Bottke D, Bronner C, Steiner U, Siegmann A, Golz R, Störkel S, Willich N, Semjonow A, Stöckle M, Rübe C, Rebmann U, Kälble T, Feldmann HJ, Wirth M, Hofmann R, Engenhart-Cabillic R, Hinke A, Hinkelbein W, Miller K.

Eur Urol. 2014 Aug;66(2):243-50. doi: 10.1016/j.eururo.2014.03.011. Epub 2014 Mar 21.

PMID:
24680359
14.

The QUIRO Study (assurance of quality and innovation in radiooncology): methodology, instruments and practices.

Dunst J, Willich N, Sack H, Engenhart-Cabillic R, Budach V, Popp W.

Strahlenther Onkol. 2014 Feb;190(2):138-48. doi: 10.1007/s00066-013-0555-3. Epub 2014 Jan 11.

PMID:
24408057
15.

Pelvic Ewing sarcomas. Three-dimensional conformal vs. intensity-modulated radiotherapy.

Mounessi FS, Lehrich P, Haverkamp U, Willich N, Bölling T, Eich HT.

Strahlenther Onkol. 2013 Apr;189(4):308-14. doi: 10.1007/s00066-012-0304-z. Epub 2013 Feb 28.

PMID:
23443613
16.

Evaluation of different biomarkers to predict individual radiosensitivity in an inter-laboratory comparison--lessons for future studies.

Greve B, Bölling T, Amler S, Rössler U, Gomolka M, Mayer C, Popanda O, Dreffke K, Rickinger A, Fritz E, Eckardt-Schupp F, Sauerland C, Braselmann H, Sauter W, Illig T, Riesenbeck D, Könemann S, Willich N, Mörtl S, Eich HT, Schmezer P.

PLoS One. 2012;7(10):e47185. doi: 10.1371/journal.pone.0047185. Epub 2012 Oct 23.

17.

[Technical and methodical developments of radiation oncology from a physician's point of view].

Willich N.

Strahlenther Onkol. 2012 Nov;188 Suppl 3:253-62. doi: 10.1007/s00066-012-0190-4. German.

PMID:
22895626
18.

Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial.

Blank E, Willich N, Fietkau R, Popp W, Schaller-Steiner J, Sack H, Wenz F.

Strahlenther Onkol. 2012 Feb;188(2):113-9. doi: 10.1007/s00066-011-0020-0. Epub 2012 Jan 14.

PMID:
22241435
19.

Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategy.

Brandts CH, Schulz C, Willich N, Steffen B, Hardes J, Gosheger G, Winkelmann W, Serve H, Heinecke A, Berdel WE, Thomas M.

Cancer Chemother Pharmacol. 2012 Mar;69(3):613-20. doi: 10.1007/s00280-011-1731-8. Epub 2011 Sep 24.

PMID:
21947168
20.

Retrospective, monocentric analysis of late effects after Total Body Irradiation (TBI) in adults.

Bölling T, Kreuziger DC, Ernst I, Elsayed H, Willich N.

Strahlenther Onkol. 2011 May;187(5):311-5. doi: 10.1007/s00066-011-2190-1. Epub 2011 Apr 26.

PMID:
21533759
21.

Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the "Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence" (RiSK).

Bölling T, Geisenheiser A, Pape H, Martini C, Rübe C, Timmermann B, Fischedick K, Kortmann RD, Gerss J, Koch R, Willich N.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e787-91. doi: 10.1016/j.ijrobp.2010.10.037. Epub 2010 Dec 16.

PMID:
21167655
22.

[Seed migration to the vertebral venous plexus after prostate brachytherapy].

Wagner W, Willich N, Radmard A, Christ A, Fleig PW, Krukemeyer MG.

Urologe A. 2010 Nov;49(11):1390-2. doi: 10.1007/s00120-010-2382-9. German.

PMID:
20835698
23.

[The significance of radiation therapy for symptomatic vertebral hemangiomas (SVH)].

Heyd R, Seegenschmiedt MH, Rades D, Winkler C, Eich HT, Bruns F, Gosheger G, Willich N, Micke O; German Cooperative Group on Radiotherapy Benign Diseases (GCG-BD).

Strahlenther Onkol. 2010 Aug;186(8):430-5. doi: 10.1007/s00066-010-2140-3. Epub 2010 Jul 29. German.

PMID:
20803283
24.

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

Eich HT, Diehl V, Görgen H, Pabst T, Markova J, Debus J, Ho A, Dörken B, Rank A, Grosu AL, Wiegel T, Karstens JH, Greil R, Willich N, Schmidberger H, Döhner H, Borchmann P, Müller-Hermelink HK, Müller RP, Engert A.

J Clin Oncol. 2010 Sep 20;28(27):4199-206. doi: 10.1200/JCO.2010.29.8018. Epub 2010 Aug 16.

PMID:
20713848
25.

Heterogeneity of radiation- and TNF-alpha-induced programmed cell death in carcinoma, sarcoma and lymphoma cell lines.

Bölling T, Kolkmeyer A, Greve B, Ernst I, Willich N, Könemann S.

Anticancer Res. 2010 Jul;30(7):2857-61.

PMID:
20683023
26.

Association of telomerase activity with radio- and chemosensitivity of neuroblastomas.

Wesbuer S, Lanvers-Kaminsky C, Duran-Seuberth I, Bölling T, Schäfer KL, Braun Y, Willich N, Greve B.

Radiat Oncol. 2010 Jul 19;5:66. doi: 10.1186/1748-717X-5-66.

27.

Dose-volume analysis of radiation nephropathy in children: preliminary report of the risk consortium.

Bölling T, Ernst I, Pape H, Martini C, Rübe C, Timmermann B, Fischedick K, Kortmann RD, Willich N.

Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):840-4. doi: 10.1016/j.ijrobp.2010.03.021. Epub 2010 Jul 16.

PMID:
20638187
28.

Acute toxicity profile of radiotherapy in 690 children and adolescents: RiSK data.

Selo N, Bölling T, Ernst I, Pape H, Martini C, Rübe C, Timmermann B, Fischedick K, Kortmann RD, Gerss J, Koch R, Willich N.

Radiother Oncol. 2010 Oct;97(1):119-26. doi: 10.1016/j.radonc.2010.04.030. Epub 2010 May 31.

PMID:
20605649
29.

Long-term overall and cardiovascular mortality after childhood cancer: the problem of retrospective estimated radiation doses.

Bölling T, Willich N.

J Clin Oncol. 2010 Sep 1;28(25):e436; author reply e437-8. doi: 10.1200/JCO.2010.28.6872. Epub 2010 Jun 21. No abstract available.

PMID:
20566992
30.

Late effects of abdominal irradiation in children: a review of the literature.

Bölling T, Willich N, Ernst I.

Anticancer Res. 2010 Jan;30(1):227-31. Review.

PMID:
20150640
31.

Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology.

Muecke R, Schomburg L, Glatzel M, Berndt-Skorka R, Baaske D, Reichl B, Buentzel J, Kundt G, Prott FJ, Devries A, Stoll G, Kisters K, Bruns F, Schaefer U, Willich N, Micke O; German Working Group Trace Elements and Electrolytes in Oncology-AKTE.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):828-35. doi: 10.1016/j.ijrobp.2009.08.013. Epub 2010 Feb 3.

PMID:
20133068
32.

PET in the diagnosis and management of patients with brain metastasis: current role and future perspectives.

Waerzeggers Y, Rahbar K, Riemann B, Weckesser M, Schäfers M, Hesselmann V, Niederstadt T, Willich N, Stummer W, Paulus W, Schober O, Jacobs AH.

Cancer Biomark. 2010;7(4):219-33. doi: 10.3233/CBM-2010-0200. Review.

PMID:
21576815
33.

Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review.

Heyd R, Seegenschmiedt MH, Rades D, Winkler C, Eich HT, Bruns F, Gosheger G, Willich N, Micke O; German Cooperative Group on Radiotherapy for Benign Diseases.

Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):217-25. doi: 10.1016/j.ijrobp.2009.04.055. Epub 2009 Aug 21. Review.

PMID:
19699592
34.

Radiation toxicity following busulfan/melphalan high-dose chemotherapy in the EURO-EWING-99-trial: review of GPOH data.

Bölling T, Dirksen U, Ranft A, Ernst I, Jürgens H, Willich N.

Strahlenther Onkol. 2009 Aug;185 Suppl 2:21-2. doi: 10.1007/s00066-009-1009-9. No abstract available.

PMID:
19685030
35.

Evaluation of side effects after radiotherapy in childhood and adolescence: from retrospective case reports to a prospective, multicentric and transnational approach.

Willich N, Ernst I, Pape H, Rübe C, Timmermann B, Asadpour B, Kortmann RD, Bölling T.

Strahlenther Onkol. 2009 Aug;185 Suppl 2:3-4. doi: 10.1007/s00066-009-1003-2. No abstract available.

PMID:
19685024
36.

3rd Münster symposium on late effects after tumor therapy in childhood and adolescence. Foreword.

Willich N, Bölling T.

Strahlenther Onkol. 2009 Aug;185 Suppl 2:1-2. doi: 10.1007/s00066-009-1002-3. No abstract available.

PMID:
19685023
37.

Kidney-autotransplantation before radiotherapy: a case report.

Bölling T, Janke K, Wolters HH, Glashörster M, Ernst I, Willich N, Brockmann J, Könemann S.

Anticancer Res. 2009 Aug;29(8):3397-400.

38.

Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

Wiegel T, Bottke D, Steiner U, Siegmann A, Golz R, Störkel S, Willich N, Semjonow A, Souchon R, Stöckle M, Rübe C, Weissbach L, Althaus P, Rebmann U, Kälble T, Feldmann HJ, Wirth M, Hinke A, Hinkelbein W, Miller K.

J Clin Oncol. 2009 Jun 20;27(18):2924-30. doi: 10.1200/JCO.2008.18.9563. Epub 2009 May 11.

PMID:
19433689
39.

Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer.

Paskeviciute B, Bölling T, Brinkmann M, Rudykina G, Ernst I, Stegger L, Schober O, Willich N, Weckesser M, Könemann S.

Strahlenther Onkol. 2009 Apr;185(4):260-5. doi: 10.1007/s00066-009-1962-3. Epub 2009 Apr 16.

PMID:
19370430
40.

Long-term results of radiotherapy in primary carcinoma of the vagina.

Hegemann S, Schäfer U, Lellé R, Willich N, Micke O.

Strahlenther Onkol. 2009 Mar;185(3):184-9. doi: 10.1007/s00066-009-1930-y. Epub 2009 Mar 28.

PMID:
19330296
41.

Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer - results after 874 patient-years of follow-up in the MSDS-trial.

Biermann M, Pixberg M, Riemann B, Schuck A, Heinecke A, Schmid KW, Willich N, Dralle H, Schober O; MSDS study group.

Nuklearmedizin. 2009;48(3):89-98; quiz N15. doi: 10.3413/nukmed-0221. Epub 2009 Mar 23.

PMID:
19322503
42.

Perioperative high-dose rate brachytherapy using a bendy applicator (flab): treatment results of 74 patients.

Bölling T, Schüller P, Distelmaier B, Schuck A, Ernst I, Gosheger G, Winkelmann W, Dirksen U, Jürgens H, Kronholz HL, Willich N, Könemann S.

Anticancer Res. 2008 Nov-Dec;28(6B):3885-90.

43.

Multicentric investigation of ionising radiation-induced cell death as a predictive parameter of individual radiosensitivity.

Greve B, Dreffke K, Rickinger A, Könemann S, Fritz E, Eckardt-Schupp F, Amler S, Sauerland C, Braselmann H, Sauter W, Illig T, Schmezer P, Gomolka M, Willich N, Bölling T.

Apoptosis. 2009 Feb;14(2):226-35. doi: 10.1007/s10495-008-0294-6.

PMID:
19142732
44.

Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG).

Eich HT, Müller RP, Engenhart-Cabillic R, Lukas P, Schmidberger H, Staar S, Willich N; German Hodgkin Study Group.

Strahlenther Onkol. 2008 Aug;184(8):406-10.

PMID:
18956517
45.

Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer.

Thomas M, Rübe C, Hoffknecht P, Macha HN, Freitag L, Linder A, Willich N, Hamm M, Sybrecht GW, Ukena D, Deppermann KM, Dröge C, Riesenbeck D, Heinecke A, Sauerland C, Junker K, Berdel WE, Semik M; German Lung Cancer Cooperative Group.

Lancet Oncol. 2008 Jul;9(7):636-48. doi: 10.1016/S1470-2045(08)70156-6. Epub 2008 Jun 24.

PMID:
18583190
46.

Late effects of thoracic irradiation in children.

Bölling T, Könemann S, Ernst I, Willich N.

Strahlenther Onkol. 2008 Jun;184(6):289-95. doi: 10.1007/s00066-008-1842-2. Review.

PMID:
18535803
47.

Pediatric radiation oncology in Germany: a study of availability and application.

Bölling T, Ernst I, Könemann S, Willich N.

Klin Padiatr. 2008 May-Jun;220(3):178-82. doi: 10.1055/s-2008-1065325.

PMID:
18478491
48.

Study protocol of the German "Registry for the detection of late sequelae after radiotherapy in childhood and adolescence" (RiSK).

Bolling T, Schuck A, Pape H, Rube C, Pollinger B, Timmermann B, Kortmann RD, Dieckmann K, Willich N.

Radiat Oncol. 2008 Apr 21;3:10. doi: 10.1186/1748-717X-3-10.

49.

Whole lung irradiation in patients with exclusively pulmonary metastases of Ewing tumors. Toxicity analysis and treatment results of the EICESS-92 trial.

Bölling T, Schuck A, Paulussen M, Dirksen U, Ranft A, Könemann S, Dunst J, Willich N, Jürgens H.

Strahlenther Onkol. 2008 Apr;184(4):193-7. doi: 10.1007/s00066-008-1810-x.

PMID:
18398583
50.

Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma: an analysis of the German Hodgkin Study Group.

Eich HT, Engenhart-Cabillic R, Hansemann K, Lukas P, Schneeweiss A, Seegenschmiedt H, Skripnitchenko R, Staar S, Willich N, Müller RP.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1419-24. doi: 10.1016/j.ijrobp.2007.12.002. Epub 2008 Jan 30.

PMID:
18234433

Supplemental Content

Loading ...
Support Center